Citation Impact
Citing Papers
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Inflammation and cancer
2002 StandoutNature
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
2001
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
2005
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
2003
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
2000
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Tolerance and Autoimmunity
2001
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
1999
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
The development of allergic inflammation
2008 StandoutNature
Inflammatory Bowel Disease
2002 Standout
Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
1998
Anti-Inflammatory Cytokines
2000
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
1998
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
1998
Inflammation and cancer: back to Virchow?
2001 Standout
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
2007
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
2013
Etanercept as Monotherapy in Patients with Psoriasis
2003
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
The TNF and TNF Receptor Superfamilies
2001 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Frailty in elderly people
2013 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Drug Treatment for Rheumatoid Arthritis
1999
Pathogen Recognition and Innate Immunity
2006 Standout
Anemia of Chronic Disease
2005 Standout
Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly
1999
TNFRSF1A mutations and autoinflammatory syndromes
2000
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
2002
Anti-Cytokine Therapy for Rheumatoid Arthritis
2000
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Etanercept Therapy in Rheumatoid Arthritis
1999
TNF-R1 Signaling: A Beautiful Pathway
2002 StandoutScience
Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events
1999
Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
2004
Interleukin 6 plays a key role in the development of antigen-induced arthritis
1998
Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice
2002
Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges
2005
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001
Interleukin 15: biology and relevance to human disease
2001
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure
1999
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
New α-Substituted Succinate-Based Hydroxamic Acids as TNFα Convertase Inhibitors
1999
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Works of Robert E. Ettlinger being referenced
Treatment of Osteoarthritis with a Once-Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial
2000
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extension
1999
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997